DBV Technologies Future Growth
Future criteria checks 2/6
DBV Technologies is forecast to grow earnings and revenue by 3.5% and 54.6% per annum respectively.
Key information
3.5%
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 37.8% |
| Revenue growth rate | 54.6% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 25 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6 | -124 | -183 | -119 | 1 |
| 12/31/2025 | 5 | -119 | -172 | -114 | 1 |
| 12/31/2024 | 5 | -128 | -160 | -110 | 2 |
| 6/30/2024 | 14 | -88 | -105 | -103 | N/A |
| 3/31/2024 | 15 | -80 | -95 | -94 | N/A |
| 12/31/2023 | 16 | -73 | -80 | -80 | N/A |
| 9/30/2023 | 6 | -101 | -90 | -90 | N/A |
| 6/30/2023 | 5 | -101 | -91 | -90 | N/A |
| 3/31/2023 | 4 | -100 | -76 | -75 | N/A |
| 12/31/2022 | 5 | -96 | -56 | -56 | N/A |
| 9/30/2022 | 9 | -71 | -52 | -51 | N/A |
| 6/30/2022 | 8 | -77 | -55 | -53 | N/A |
| 3/31/2022 | 5 | -85 | -74 | -74 | N/A |
| 12/31/2021 | 6 | -98 | -109 | -108 | N/A |
| 9/30/2021 | 2 | -124 | -124 | -123 | N/A |
| 6/30/2021 | 4 | -131 | -144 | -142 | N/A |
| 3/31/2021 | 9 | -148 | -154 | -152 | N/A |
| 12/31/2020 | 11 | -160 | -168 | -166 | N/A |
| 9/30/2020 | 17 | -161 | -157 | -153 | N/A |
| 6/30/2020 | 16 | -171 | -156 | -151 | N/A |
| 3/31/2020 | 16 | -169 | -161 | -156 | N/A |
| 12/31/2019 | 15 | -172 | -154 | -148 | N/A |
| 9/30/2019 | 12 | -176 | -156 | -151 | N/A |
| 6/30/2019 | 13 | -198 | -176 | -169 | N/A |
| 3/31/2019 | 13 | -191 | -166 | -160 | N/A |
| 12/31/2018 | 13 | -190 | -162 | -157 | N/A |
| 9/30/2018 | 11 | -178 | -164 | -157 | N/A |
| 6/30/2018 | 11 | -172 | -150 | -145 | N/A |
| 3/31/2018 | 11 | -182 | N/A | -147 | N/A |
| 12/31/2017 | 12 | -177 | N/A | -137 | N/A |
| 9/30/2017 | 11 | -169 | N/A | -118 | N/A |
| 6/30/2017 | 11 | -157 | N/A | -97 | N/A |
| 3/31/2017 | 9 | -135 | N/A | -77 | N/A |
| 12/31/2016 | 8 | -121 | N/A | -63 | N/A |
| 9/30/2016 | 8 | -109 | N/A | -58 | N/A |
| 6/30/2016 | 8 | -88 | N/A | -49 | N/A |
| 3/31/2016 | 8 | -72 | N/A | -41 | N/A |
| 12/31/2015 | 7 | -49 | N/A | -29 | N/A |
| 9/30/2015 | 6 | -40 | N/A | -28 | N/A |
| 6/30/2015 | 6 | -30 | N/A | -25 | N/A |
| 3/31/2015 | 5 | -27 | N/A | -23 | N/A |
| 12/31/2014 | 6 | -29 | N/A | -25 | N/A |
| 9/30/2014 | 6 | -30 | N/A | -24 | N/A |
| 6/30/2014 | 7 | -32 | N/A | -25 | N/A |
| 3/31/2014 | 6 | -28 | N/A | -21 | N/A |
| 12/31/2013 | 5 | -27 | N/A | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0QAJ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0QAJ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0QAJ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0QAJ's revenue (54.6% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: 0QAJ's revenue (54.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0QAJ's Return on Equity is forecast to be high in 3 years time